Investing.com - Financial Markets Worldwide

ACI Formulations Ltd (ACIF)

DSE
Currency in BDT
141.30
+1.60(+1.15%)
Closed·

ACIF Financial Summary

Key Ratios

P/E Ratio13.22
Price/Book1.6
Debt / Equity108.83%
Return on Equity12.69%
Dividend Yield1.42%
EBITDA627.79M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2014
31/12
2016
30/06
2017
30/06
2018
30/06
2019
30/06
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa3,424.043,864.534,247.424,959.814,935.45
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa1,066.761,126.681,218.311,316.941,427.66
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa344.2417.77453.65494.82580.17
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa92.73213.46242.88234.92324.94
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa5,514.855,659.966,469.386,674.327,559.15
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa3,035.522,555.123,253.743,324.874,024.92
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa2,401.863,004.693,112.573,052.673,259.64
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa357.7352.04-902.52-3.83-427.45
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa653.5604.14341.8211.17698.31
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-23.65-13.02-31.35-114.09-110.01
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-627.29-679.2-284.3149.55-643.42
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa2.68-88.0826.53-53.34-55.05
* In Millions of BDT (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 9.14%
Dividend Yield
1.42%
Industry Median 9.93%
Annualised payout
2.00
Paid annually
5-Years Growth
-9.71%
Growth Streak
Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
1.89 / --
Revenue / Forecast
1.30B / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were ACI Formulations's earnings for the latest quarter?

The ACI Formulations EPS (TTM) is 9.14. ACI Formulations reported sales of 1,300.07, net income of 89.40, and EPS of 1.89 for the latest quarter.

What was ACI Formulations's net income for the latest quarter?

ACI Formulations's net income for the latest quarter was 89.40.

How did ACI Formulations's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,610.92 in the previous quarter to 1,300.07 in the latest quarter, and net income moved from 208.49 to 89.40 compared to the previous quarter.

What is ACI Formulations's net profit margin on a TTM basis?

ACI Formulations's trailing twelve months (TTM) net profit margin is 6.58%.

How does ACI Formulations's debt to equity ratio compare to industry standards?

ACI Formulations's total debt-to-equity ratio is 108.83%.

What is ACI Formulations's return on investment on a TTM basis?

ACI Formulations's trailing twelve months (TTM) return on investment (ROI) is 12.69%.

Did ACI Formulations gain or lose cash last quarter?

In the latest quarter, ACI Formulations's net change in cash was -165.29 million.

What were ACI Formulations's total assets and liabilities in the latest quarter?

As of the latest quarter, ACI Formulations reported total assets of 8,460.54 million and total liabilities of 4,606.92 million.

How has ACI Formulations's total revenue grown this year?

ACI Formulations's total revenue was 1,610.92 in the previous quarter and 1,300.07 in the latest quarter.

What is ACI Formulations's gross margin on a TTM basis?

ACI Formulations's trailing twelve months (TTM) gross margin is 32.90%.

What was ACI Formulations's revenue per share for the latest quarter?

ACI Formulations's revenue per share for the latest quarter was 458.51.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.